Should all patients with psoriasis receive statins? Analysis according to different strategies,
Abstract Background: Different strategies have been proposed for the cardiovascular risk management of patients with psoriasis. Objective: To estimate the cardiovascular risk and evaluate two cardiovascular prevention strategies in patients with psoriasis, analyzing which proportion of patients woul...
Saved in:
Main Authors: | Walter Masson (Author), Martín Lobo (Author), Graciela Molinero (Author), Emiliano Rossi (Author) |
---|---|
Format: | Book |
Published: |
Sociedade Brasileira de Dermatologia,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxoplasmosis in a patient receiving ixekizumab for psoriasis
by: Yolanka Lobo, BPhysio, MBBS, et al.
Published: (2020) -
Should we consider all statins the same? A reasonable approach from a rural GP may limit iatrogenic burden
by: Cecilia Soavi, et al.
Published: (2022) -
Peripheral polyneuropathy in patients receiving long-term statin therapy
by: Öner Özdogan
Published: (2019) -
Peripheral polyneuropathy in patients receiving long-term statin therapy
by: Ibrahim Halil Özdemir, et al.
Published: (2019) -
STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE
by: V. V. Samoylenko, et al.
Published: (2015)